lubiprostone 使用与头痛之间的关联:随机对照试验的系统审查和元分析
Satoru Mitsuboshi1,2, Makoto Morizumi3, Shungo Imai2
1Department of Pharmacy, Kaetsu Hospital, Niigata, Japan.
British journal of clinical pharmacology
|October 3, 2025
概括
抗便秘药物卢比普罗与更高的头痛发病率有关. 这一系统性审查和元分析证实了与 lubiprostone 使用相关的头痛风险增加.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 临床研究 临床研究
背景情况:
- 路比激活前列腺素受体,可能增加头痛风险.
- 有关 lubiprostone 与不良头痛事件的关联存在担忧.
- 需要进行全面的分析来量化这种风险.
研究的目的:
- 系统地审查和元分析随机对照试验 (RCT).
- 为了确定 lubiprostone 与安慰剂或其他药相比是否显著增加头痛的风险.
- 评估成人和儿童群体的头痛风险.
主要方法:
- 在MEDLINE,ClinicalTrials.gov和Cochrane中央注册表中搜索了相关的RCT.
- 包括比较 lubiprostone 与安慰剂或其他药的研究.
- 使用DerSimonian-Laird随机效应模型来估计风险比率 (RR) 和GRADE来确定证据评估.
主要成果:
- 分析了26个涉及6265名患者的RCT.
- 卢比普罗显示头痛风险增加了32% (RR 1.32,95% CI 1.02-1.71) 具有中等的确定性.
- 头痛风险在成年人中升高 (RR 1.23) 和在儿童中显著增加 (RR 3.07,确定性非常低).
结论:
- 路比普治疗与头痛风险增加有关.
- 这些发现支持需要仔细考虑头痛作为潜在的副作用的必要性.
- 进一步的研究可能是有必要的,以澄清风险,特别是在儿科患者群体.
相关概念视频
01:21Drugs for Treatment of Constipation-Predominant IBS
724
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
724
01:17Drugs for Treatment of Diarrhea-Predominant IBS
634
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
634
01:25Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
672
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
672